Obesity as a Potential Risk Factor for Vincristine Induced Peripheral Neuropathy

Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer. Vincristine is a core chemotherapeutic agent for patients with ALL; unfortunately, approximately 78% will develop vincristine-induced peripheral neuropathy (VIPN). VIPN can result in vincristine dose reductions that decrease the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Pediatr Hematol Oncol
Autores principales: Sajdyk, Tammy J., Boyle, Frances A., Foran, Kaitlin S., Tong, Yan, Pandya, Pankita, Smith, Ellen M. L., Ho, Richard H., Wells, Elizabeth, Renbarger, Jamie L.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7165027/
https://ncbi.nlm.nih.gov/pubmed/31634238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPH.0000000000001604
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares